Facebook tracking pixel

Coming Soon

S10.AI's Next-Generation Telehealth Platform

F33.9
ICD-10-CM
Recurrent Major Depressive Disorder

Find information on recurrent major depressive disorder (MDD) diagnosis, including clinical documentation requirements, ICD-10-CM code F33.x, DSM-5 criteria, and treatment guidelines. Learn about accurate medical coding for recurrent depression, differential diagnosis considerations, and best practices for healthcare professionals documenting recurring major depressive episodes in patient charts. This resource offers support for proper diagnosis coding and effective clinical management of recurrent MDD.

Also known as

Recurrent MDD
Chronic Recurrent Major Depressive Disorder

Diagnosis Snapshot

Key Facts
  • Definition : Recurring episodes of major depression, impacting mood, thoughts, and behavior.
  • Clinical Signs : Sadness, loss of interest, fatigue, sleep changes, appetite changes, difficulty concentrating.
  • Common Settings : Outpatient therapy, primary care, psychiatry, partial hospitalization, telehealth.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC F33.9 Coding
F33

Recurrent depressive disorders

Covers various recurrent major depressive episodes.

F32

Major depressive disorder, single episode

While not recurrent, relevant for initial episodes.

F41

Anxiety disorders

Often co-occurs with and can influence depression.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is this a current episode of Major Depressive Disorder?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Recurring major depressive episodes
Persistent Depressive Disorder (Dysthymia)
Bipolar II Disorder

Documentation Best Practices

Documentation Checklist
  • Document DSM-5 criteria for recurrent major depressive disorder
  • Specify current episode severity: mild, moderate, severe
  • Note recurrence: at least two major depressive episodes
  • Document symptom duration and frequency
  • Assess and document psychosocial impact/functional impairment

Coding and Audit Risks

Common Risks
  • Unconfirmed Recurrence

    Insufficient documentation to support recurrent episode, leading to incorrect coding of single episode (F32.9 vs F33.x).

  • Severity Miscoding

    Missing documentation of symptom severity (mild, moderate, severe) impacting accurate coding and reimbursement (F33.0-F33.2).

  • Partial Remission Coding

    Inadequate documentation differentiating partial remission from full remission or a new episode, affecting accurate diagnosis coding (F33.4x).

Mitigation Tips

Best Practices
  • Document symptom duration, frequency, and severity for accurate MDD coding (ICD-10 F33.x).
  • Ensure CDI aligns documentation with recurrent MDD diagnostic criteria for compliance.
  • Assess and document past major depressive episodes and remission periods for proper coding.
  • Evaluate and document functional impairment due to MDD for improved care and coding accuracy.
  • Review medical necessity criteria for treatments and document thoroughly for compliance.

Clinical Decision Support

Checklist
  • Verify DSM-5 criteria for major depressive episode: ICD-10 F33.x, F32.x documentation
  • Confirm two or more distinct major depressive episodes, separated by at least 2 months
  • Rule out medical/substance-induced causes, document differential diagnosis assessment
  • Assess symptom severity PHQ-9, GAD-7 scores, suicide risk, functional impairment
  • Document recurrence timeframe, treatment history, response, plan, and patient education

Reimbursement and Quality Metrics

Impact Summary
  • Recurrent Major Depressive Disorder reimbursement hinges on accurate ICD-10-CM coding (F33.x) and reporting for optimal payer reimbursement.
  • Quality metrics for Recurrent Major Depressive Disorder impact hospital value-based purchasing programs tied to PHQ-9 scores and remission rates.
  • Coding accuracy for depression severity, episode duration, and treatment type directly affects reimbursement and quality reporting.
  • Proper documentation of symptom assessment, treatment plan, and patient response is crucial for Recurrent Major Depressive Disorder reimbursement justification.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Quick Tips

Practical Coding Tips
  • Document MDD recurrence, F33.x
  • Specify episode severity/type
  • Confirm DSM-5 criteria, F33
  • Check past MDD diagnosis
  • Code chronic MDD if applicable

Documentation Templates

Patient presents with recurrent major depressive disorder (MDD), fulfilling DSM-5 diagnostic criteria for a recurrent episode.  The patient reports persistent depressed mood, anhedonia, and significant changes in sleep and appetite lasting for over two weeks.  Symptoms include insomnia, fatigue, feelings of worthlessness, diminished concentration, and recurrent thoughts of death, though no specific suicidal plan or intent was reported at this time.  This represents the patient's third major depressive episode, with previous episodes documented in 2018 and 2020.  The patient denies manic or hypomanic episodes.  Medical history includes hypothyroidism, well-controlled with levothyroxine.  Family history is positive for depression and anxiety disorders.  Current medications include levothyroxine.  Mental status exam reveals a patient who appears sad and tearful, with psychomotor retardation.  Affect is constricted and mood is depressed.  Thought processes are linear and goal-directed, though thought content is notable for negative ruminations.  Insight and judgment appear intact.  Diagnosis of recurrent major depressive disorder, single episode, moderate severity, is confirmed.  Treatment plan includes initiation of sertraline 50mg daily, with titration as tolerated, and referral for individual psychotherapy with a focus on cognitive behavioral therapy (CBT).  Patient education provided regarding medication side effects, potential drug interactions, and importance of medication adherence.  Risks and benefits of treatment discussed.  Follow-up appointment scheduled in two weeks to assess treatment response and adjust medication as needed.  Patient provided with crisis hotline information and encouraged to reach out for support as needed.  Differential diagnoses considered included adjustment disorder with depressed mood and medical causes of depressive symptoms, but ruled out based on clinical presentation and history.  Coding considerations include F33.1 for recurrent major depressive disorder, current episode moderate.